Related Experiment Videos
Blood substitutes and redox responses in the microcirculation
1Department of Physiology, College of Medicine, University of Arizona, Tucson, AZ 85724-5051, USA. abaldwin@u.arizona.edu
Antioxidants & Redox Signaling
|November 19, 2004
Summary
Hemoglobin-based blood substitutes can cause organ damage due to reactive oxygen species. Strategies to mitigate these harmful effects are crucial for patient safety and effective microvascular function.
Area of Science:
- Biomedical Engineering
- Pharmacology
- Cell Biology
Background:
- Hemoglobin-based blood substitutes (HBBS) show promise for oxygen transport but have caused organ dysfunction in clinical trials.
- Cell-free hemoglobin can generate reactive oxygen species (ROS), posing risks, especially to vulnerable patients with compromised antioxidant status.
- Oxidative damage in the microcirculation disrupts fluid balance and affects drug and endogenous molecule delivery.
Purpose of the Study:
- To review the redox chemistry of HBBS.
- To discuss the impact of HBBS on endothelial cells and microvascular exchange properties.
- To evaluate methods for reducing HBBS-induced oxidative damage and explore protective cell signaling pathways.
Main Methods:
- Review of existing experimental evidence on HBBS-induced oxidative stress.
- Analysis of the redox chemistry of cell-free hemoglobin.
- Discussion of in vitro and in vivo studies on HBBS effects on microvasculature and endothelial cells.
Main Results:
- HBBS can induce significant oxidative damage, particularly in the microcirculation.
- Patients with poor antioxidant status are at higher risk from HBBS.
- Modified hemoglobins can trigger cell signaling pathways in endothelial cells.
Conclusions:
- Understanding the redox chemistry of HBBS is key to identifying risks.
- Mitigation strategies are needed to reduce deleterious effects of HBBS.
- Further research into cell signaling pathways may offer protective mechanisms for microvascular function.